Mouse models of hypertension

Drug Discovery Today: Disease Models

Volumn 3, Issue 3, 2006, Pages 273-281

  Monassier, Laurent ^a   Combe, Roy ^a   Fertak, Lahcen El ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; BETA ADRENERGIC RECEPTOR; CARRIER PROTEIN; CELL ADHESION MOLECULE; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE; DOPAMINE BETA MONOOXYGENASE; ENDOTHELIN; LEPTIN; N(G) NITROARGININE METHYL ESTER; NATRIURETIC FACTOR; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; RECEPTOR PROTEIN; RENIN; SODIUM CHLORIDE;

AGE DISTRIBUTION; ANIMAL MODEL; BLOOD PRESSURE MEASUREMENT; DEVELOPING COUNTRY; DIET; DISEASE MODEL; ESSENTIAL HYPERTENSION; EXPERIMENTAL ANIMAL; GENETIC MODEL; GENETIC VARIABILITY; HYPERTENSION; INCIDENCE; MOLECULAR GENETICS; MOUSE; MULTIFACTORIAL INHERITANCE; NONHUMAN; OBESITY; PHENOTYPIC VARIATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT INTAKE; SEX RATIO; STRAIN DIFFERENCE; WESTERN HEMISPHERE;

EID: 33751243621     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.10.008     Document Type: Review

References (50)

1. Monassier L., and Contantinesco A. Cardiovascular disorders: insights into in vivo cardiovascular phenotyping. In: Hrabé de Angelis M., et al. (Ed). Standards of Mouse Model Phenotyping (2006), Wiley-VCH 177-199
2. Cervenka L., et al. Genetic inactivation of the B2 receptor in mice worsens two-kidney, one-clip hypertension: role of NO and the AT2 receptor. J. Hypertens. 21 (2003) 1531-1538
3. Svenson K.L., et al. Invited review: Identifying new mouse models of cardiovascular disease: a review of high-throughput screens of mutagenized and inbred strains. J. Appl. Physiol. 94 (2003) 1650-1659
4. Deschepper C.F., et al. Characterization of blood pressure and morphological traits in cardiovascular-related organs in 13 different inbred mouse strains. J. Appl. Physiol. 97 (2004) 369-376
5. Tsukahara C., et al. Blood pressure in 15 inbred mouse strains and its lack of relation with obesity and insulin resistance in the progeny of an NZO/HILtJ × C3H/HeJ intercross. Mamm. Genome 15 (2004) 943-950
6. Han J., et al. Age-related changes in blood pressure in the senescence-accelerated mouse (SAM): aged SAMP1 mice manifest hypertensive vascular disease. Lab. Anim. Sci. 48 (1998) 256-263
7. Lerman L.O., et al. Animal models of hypertension: an overview. J. Lab. Clin. Med. 146 (2005) 160-173
8. Wiesel P., et al. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 29 (1997) 1025-1030
9. Tyagi N., et al. Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model. Can. J. Physiol. Pharmacol. 83 (2005) 583-594
10. Peng H., et al. Effects of angiotensin-converting enzyme inhibitor and angiotensin type 1 receptor antagonist in deoxycorticosterone acetate-salt hypertensive mice lacking Ren-2 gene. Hypertension 37 (2001) 974-980
11. Perez-Rivera A.A., et al. Alpha-1B adrenoceptors mediate neurogenic constriction in mesenteric arteries of normotensive and DOCA-salt hypertensive mice. Auton. Neurosci. 121 (2005) 64-73
12. Landmesser U., et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40 (2002) 511-515
13. Byrne J.A., et al. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 93 (2003) 802-805
14. Johar S., et al. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. Faseb J. 20 (2006) 1546-1548
15. Matsuno K., et al. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112 (2005) 2677-2685
16. Zimmerman M.C., et al. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ. Res. 95 (2004) 210-216
17. Yu Q., et al. Characterization of high-salt and high-fat diets on cardiac and vascular function in mice. Cardiovasc. Toxicol. 4 (2004) 37-46
18. Sethi S., et al. Renal thrombotic microangiopathy in a genetic model of hypertension in mice. Exp. Biol. Med. (Maywood) 231 (2006) 196-203
19. Obst M., et al. Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice. J. Hypertens. 22 (2004) 1889-1894
20. Gross V., et al. Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice. J. Hypertens. 22 (2004) 997-1005
21. Berchtold P., et al. Epidemiology of obesity and hypertension. Int. J. Obes. 5 suppl. 1 (1981) 1-7
22. Garrison R.J., et al. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev. Med. 16 (1987) 235-251
23. Jones D.W., et al. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J. Hypertens. 12 (1994) 1433-1437
24. Carroll J.F., et al. Hemodynamic alterations in hypertensive obese rabbits. Hypertension 26 (1995) 465-470
25. Rocchini A.P., et al. Clonidine prevents insulin resistance and hypertension in obese dogs. Hypertension 33 (1999) 548-553
26. Munzberg H., et al. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145 (2004) 4880-4889
27. Marsh A.J., et al. Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension 42 (2003) 488-493
28. Mark A.L., et al. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J. Hypertens. 17 (1999) 1949-1953
29. Aizawa-Abe M., et al. Pathophysiological role of leptin in obesity-related hypertension. J. Clin. Invest. 105 (2000) 1243-1252
30. Haynes W.G., et al. Sympathetic and cardiorenal actions of leptin. Hypertension 30 (1997) 619-623
31. Shek E.W., et al. Chronic leptin infusion increases arterial pressure. Hypertension 31 (1998) 409-414
32. Thiele T.E., et al. Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am. J. Physiol. 274 (1998) R248-R254
33. Mark A.L., et al. State-of-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertension 33 (1999) 537-541
34. Huszar D., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 (1997) 131-141
35. Semeniuk L.M., et al. Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H976-H982
36. Barouch L.A., et al. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108 (2003) 754-759
37. Ohashi K., et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47 (2006) 1108-1116
38. Rahmouni K., et al. Obesity-associated hypertension: new insights into mechanisms. Hypertension 45 (2005) 9-14
39. Williams T.D., et al. Diet-induced obesity and cardiovascular regulation in C57BL/6J mice. Clin. Exp. Pharmacol. Physiol. 30 (2003) 769-778
40. Schlager G., et al. Characterization of hypertensive and hypotensive inbred strains of mice. Lab. Anim. Sci. 47 (1997) 288-292
41. Schlager G. Biometrical genetic analysis of blood pressure level in the genetically hypertensive mouse. Clin. Exp. Hypertens. 16 (1994) 809-824
42. Wright F.A., et al. Genome scan for blood pressure loci in mice. Hypertension 34 (1999) 625-630
43. Audoly L.P., et al. What can knockout mice contribute to an understanding of hypertension?. Curr. Hypertens. Rep. 2 (2000) 192-197
44. Cvetkovic B., et al. Understanding hypertension through genetic manipulation in mice. Kidney Int. 57 (2000) 863-874
45. Gurley S.B., et al. Gene-targeting studies of the renin-angiotensin system: mechanisms of hypertension and cardiovascular disease. Cold Spring Harb. Symp. Quant. Biol. 67 (2002) 451-457
46. Lavoie J.L., et al. Transgenic mice for studies of the renin-angiotensin system in hypertension. Acta Physiol. Scand. 181 (2004) 571-577
47. Lele R.D. Hypertension: molecular approach. J. Assoc. Physicians India 52 (2004) 53-62
48. Lake-Bruse K.D., et al. Transgenic and knockout mice to study the renin-angiotensin system and other interacting vasoactive pathways. Curr. Hypertens. Rep. 2 (2000) 211-216
49. Methot D., et al. Knockout of renin-angiotensin system genes: effects on vascular development. Curr. Hypertens. Rep. 3 (2001) 68-73
50. Iida S., et al. Spontaneous stroke in a genetic model of hypertension in mice. Stroke 36 (2005) 1253-1258